Hughes; Steven D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hughes; Steven D..The latest application filed is for "hemostatic microspheres".
Company Profile
2.19.51
- Hughes; Steven D. - Kenmore WA
- HUGHES; Steven D. - Seattle WA
- Hughes; Steven D. - Oakland CA
Patent Activity
| Patent | Date |
|---|---|
| Hemostatic Microspheres App 20220133891 - Senderoff; Richard I. ; et al. | 2022-05-05 |
| Hemostatic microspheres Grant 11,246,938 - Senderoff , et al. February 15, 2 | 2022-02-15 |
| Hemostatic Microspheres App 20190192667 - Senderoff; Richard I. ; et al. | 2019-06-27 |
| Hemostatic microspheres Grant 10,232,046 - Senderoff , et al. | 2019-03-19 |
| Hemostatic microspheres Grant 10,124,068 - Senderoff , et al. November 13, 2 | 2018-11-13 |
| Hemostatic Microspheres App 20170189537 - Senderoff; Richard I. ; et al. | 2017-07-06 |
| Hemostatic Microspheres App 20170189538 - Senderoff; Richard I. ; et al. | 2017-07-06 |
| Hemostatic microspheres Grant 9,629,798 - Senderoff , et al. April 25, 2 | 2017-04-25 |
| Anti-IL-20 antibodies and binding partners and methods of using in inflammation Grant 8,907,068 - Xu , et al. December 9, 2 | 2014-12-09 |
| Anti-IL-TIF antibodies Grant 8,900,578 - Xu , et al. December 2, 2 | 2014-12-02 |
| Anti-il-tif Antibodies App 20130330330 - XU; Wenfeng ; et al. | 2013-12-12 |
| Anti-IL-TIF antibodies Grant 8,524,227 - Xu , et al. September 3, 2 | 2013-09-03 |
| Methods Of Treating Cancer Using Il-21 App 20120294798 - Nelson; Andrew J. ; et al. | 2012-11-22 |
| Anti-il-tif Antibodies And Methods Of Using In Inflammation App 20120189628 - Xu; Wenfeng ; et al. | 2012-07-26 |
| Human Cytokine Receptor App 20120082673 - PRESNELL; Scott R. ; et al. | 2012-04-05 |
| Human cytokine receptor Grant 8,101,381 - Presnell , et al. January 24, 2 | 2012-01-24 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20110300098 - Kindsvogel; Wayne R. ; et al. | 2011-12-08 |
| Hemostatic Microspheres App 20110125089 - Senderoff; Richard I. ; et al. | 2011-05-26 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20110086004 - Kindsvogel; Wayne R. ; et al. | 2011-04-14 |
| Methods Of Treating Cancer Using Il-21 App 20110002882 - Nelson; Andrew J. ; et al. | 2011-01-06 |
| Methods Of Treating Cancer Using Il-21 App 20100322898 - Nelson; Andrew J. ; et al. | 2010-12-23 |
| Methods Of Treating Cancer Using Il-21 App 20100316600 - Nelson; Andrew J. ; et al. | 2010-12-16 |
| Methods Of Treating Cancer Using Il-21 App 20100316599 - Nelson; Andrew J. ; et al. | 2010-12-16 |
| Methods Of Treating Cancer Using Il-21 App 20100316597 - Nelson; Andrew J. ; et al. | 2010-12-16 |
| Methods Of Treating Cancer Using Il-21 App 20100316598 - Nelson; Andrew J. ; et al. | 2010-12-16 |
| Human cytokine receptor Grant 7,851,594 - Presnell , et al. December 14, 2 | 2010-12-14 |
| Methods Of Treating Cancer Using Il-21 App 20100310505 - Nelson; Andrew J. ; et al. | 2010-12-09 |
| Human Cytokine Receptor App 20100311120 - PRESNELL; SCOTT R. ; et al. | 2010-12-09 |
| Human cytokine receptor Grant 7,790,851 - Presnell , et al. September 7, 2 | 2010-09-07 |
| Anti-IL-TIF antibodies and methods of using in inflammation Grant 7,718,172 - Xu , et al. May 18, 2 | 2010-05-18 |
| Anti-IL-TIF antibodies Grant 7,674,461 - Xu , et al. March 9, 2 | 2010-03-09 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20090269304 - KINDSVOGEL; WAYNE R. ; et al. | 2009-10-29 |
| Human Cytokine Receptor App 20090264624 - Presnell; Scott R. ; et al. | 2009-10-22 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20090087404 - Kindsvogel; Wayne R. ; et al. | 2009-04-02 |
| Anti-il-tif Antibodies And Methods Of Using In Inflammation App 20090022723 - Xu; Wenfeng ; et al. | 2009-01-22 |
| Anti-il-20 Antibodies And Binding Partners And Methods Of Using In Inflammation App 20080247945 - Xu; Wenfeng ; et al. | 2008-10-09 |
| Human Cytokine Receptor App 20080214785 - Presnell; Scott R. ; et al. | 2008-09-04 |
| Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies Grant 7,393,684 - Xu , et al. July 1, 2 | 2008-07-01 |
| Anti-il-tif Antibodies And Methods Of Using In Inflammation App 20080033148 - Xu; Wenfeng ; et al. | 2008-02-07 |
| Interleukin 21 And Tyrosine Kinase Inhibitor Combination Therapy App 20080025946 - Sivakumar; Pallavur V. ; et al. | 2008-01-31 |
| Human Cytokine Receptor App 20070299247 - Presnell; Scott R. ; et al. | 2007-12-27 |
| Human cytokine receptor Grant 7,265,203 - Presnell , et al. September 4, 2 | 2007-09-04 |
| Anti-IL-TIF antibodies and methods of making Grant 7,265,211 - Xu , et al. September 4, 2 | 2007-09-04 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20070178063 - Kindsvogel; Wayne R. ; et al. | 2007-08-02 |
| Methods of treating cancer using IL-21 App 20070128161 - Nelson; Andrew J. ; et al. | 2007-06-07 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20070122382 - Kindsvogel; Wayne R. ; et al. | 2007-05-31 |
| Methods Of Treating Cancer Using Il-21 App 20070086980 - Nelson; Andrew J. ; et al. | 2007-04-19 |
| Methods Of Treating Cancer Using Il-21 App 20070048270 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 And Monoclonal Antibody Therapy App 20070048264 - Kindsvogel; Wayne R. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070048267 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070048269 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070048268 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods of treating cancer using IL-21 App 20070048272 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070049548 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods of treating cancer using IL-21 App 20070048273 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methos of treating cancer using IL-21 App 20070048271 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070048266 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070049549 - Nelson; Andrew J. ; et al. | 2007-03-01 |
| Methods Of Treating Cancer Using Il-21 App 20070041940 - Nelson; Andrew J. ; et al. | 2007-02-22 |
| Methods of treating cancer using IL-21 and monoclonal antibody therapy App 20050265966 - Kindsvogel, Wayne R. ; et al. | 2005-12-01 |
| Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation App 20050170468 - Xu, Wenfeng ; et al. | 2005-08-04 |
| Anti-IL-20 antibodies and binding partners and methods of using in inflammation App 20050136004 - Xu, Wenfeng ; et al. | 2005-06-23 |
| Human cytokine receptor App 20050065321 - Presnell, Scott R. ; et al. | 2005-03-24 |
| Anti-IL-TIF antibodies and methods of using in inflammation App 20040023341 - Xu, Wenfeng ; et al. | 2004-02-05 |
| Methods of treating cancer using IL-21 App 20040009150 - Nelson, Andrew J. ; et al. | 2004-01-15 |
| Human cytokine receptor App 20030099608 - Presnell, Scott R. ; et al. | 2003-05-29 |
| Transgenic rabbit that expresses a functional human lipoprotein (a) Grant 6,512,161 - Rouy , et al. January 28, 2 | 2003-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 